In summary, the hypoxia inducible factor HIF1α is undoubtedly a key regulator of metabolic reprogramming in cancer cells, enabling their sustained and uninhibited growth, particularly under hypoxic conditions. The gene discussed is HIF1A; the disease is cancer.